Latest Breaking News On - Glenn schulman - Page 1 : comparemela.com

IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100

100% of treated leukemia patients achieved durable complete remission at 1-year, including high-risk and relapsed acute myeloid leukemia patients who had previously failed multiple lines of.

United statesTrishna goswamiGlenn schulmanJosephp mcguirkDrug administrationExchange commissionGlobenewswire incUniversity of kansas cancer centerEuropean hematology associationHematology associationDose levelChief medical officerSpeas professorDivision directorHematologic malignanciesCellular therapeutics

IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024

IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

British columbiaGuoling chenKate rochlinGlenn schulmanInternational society for cell gene therapyAnalytical developmentExchange commissionInternational societyGene therapyChief operating officerPoster networking receptionSenior director quality operationsSenior director analytical developmentPrivate securities litigation reform actQuarterly report

IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress

IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Trishna goswamiJosephp mcguirkGlenn schulmanEuropean hematology association congressEuropean hematology associationUniversity of kansas cancer centerExchange commissionCompany contactAnnounces upcoming presentationHematology associationChief medical officerPilot studyDonor derivedSchutte speas professorDivision directorHematologic malignancies

IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024

IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesGlenn schulmanExchange commissionAmerican association for cancer researchAnnounces new preclinical dataChimeric antigen receptor tAmerican associationCancer researchAnnual meetingChimeric antigen receptorLawrence lambChief scientific officerPrivate securities litigation reform actAnnual report

IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024

- Preclinical data supports potential for proprietary nsCAR platform to selectively eliminate cancer cells while preserving healthy tissue - Gamma.

United statesGlenn schulmanAmerican association for cancer researchExchange commissionChimeric antigen receptor tAmerican associationCancer researchAnnual meetingChimeric antigen receptorLawrence lambChief scientific officerPrivate securities litigation reform actAnnual report